Biotech
New Company Aims to Improve Diabetes Treatment
A new company, spun out from Kura Oncology, has $50 million to develop a better diabetes medicine.
A big change is coming for people with diabetes. A new company just launched with a special goal. It wants to create a new kind of medicine for diabetes patients.
Kura Oncology started this new company. It will work on a next-generation treatment. This means a medicine that is much better than what we have now. A lot of money, $50 million, is ready for this work. Eli Lilly, a major drug company, supports this effort.
This new money helps the company move fast. The goal is to bring this advanced diabetes therapy to people who need it. This could mean a healthier future for many patients.
Source: FierceBiotech
#Biotech#Diabetes#Eli Lilly#Kura Oncology
More from Biotech
